حولك

Deca Durabolin: Uses, Benefits, And Side Effects

## Deca‑Durabolin (Nandrolone Decanoate)

| **Feature** | **Details** |
|-------------|--------------|
| **Generic name** | Nandrolone decanoate (also called nandrolone 17β‑decanoate) |
| **Drug class** | Synthetic anabolic–androgenic steroid (AAS) – "designer steroid" |
| **Route of administration** | Intramuscular injection (long‑acting depot; usually 50 mg–200 mg per week) |
| **Common brand names** | Deca‑Durabolin®, Nandrolone Decanoate™ (generic in many countries) |
| **FDA status** | Prescription only; approved for medical indications such as anemia, osteoporosis, and cachexia. No over‑the‑counter availability in the U.S. |
| **Key uses in medicine** | • Treating certain anemias (e.g., β‑thalassemia) by stimulating erythropoiesis
• Counteracting bone loss (osteoporosis)
• Managing muscle wasting conditions (cachexia, sarcopenia) |

---

## 2. Medical Uses of Deca‑Durabolin® (Nandrolone Decanoate)

| Condition | How Deca‑Durabolin Works | Typical Dosing & Duration |
|-----------|-------------------------|--------------------------|
| **Anemia in β‑Thalassemia** | Stimulates red‑blood‑cell production via erythropoietic effect. | 30–60 mg intramuscularly once a week, sometimes up to 6 months; dosage adjusted by CBC. |
| **Muscle wasting / Cachexia (Cancer or HIV)** | Promotes protein synthesis, improves nitrogen balance, enhances appetite. | 100 mg IM twice weekly for 2–4 weeks; maintenance dosing may follow. |
| **Osteoporosis** | Improves bone density through anabolic effect on osteoblasts. | 100 mg IM monthly (historically used; now largely supplanted by bisphosphonates). |
| **Anemia of chronic disease** | Stimulates erythropoiesis in some cases; not first-line but occasionally used. | Variable: 100–200 mg IM weekly for several weeks, monitoring Hb levels. |

*Note:* Most of these uses are historical or off-label; modern therapies (e.g., bisphosphonates, denosumab) have largely replaced many anabolic agents.

---

## 4. Side‑Effects and Contraindications

| **Side‑Effect** | **Incidence / Severity** | **Management/Prevention** |
|-----------------|--------------------------|---------------------------|
| **Gastrointestinal (Nausea, vomiting, diarrhea)** | Common with oral forms; less so with parenteral. | Antiemetics, anti‑diarrheal agents, dose adjustment. |
| **Bone‑pain flare or osteolytic pain** | Occurs during initial therapy due to rapid bone resorption. | NSAIDs/analgesics, bisphosphonate pre‑treatment may reduce severity. |
| **Hypercalcemia (rare)** | Usually mild; monitor serum calcium in high‑dose regimens. | Adequate hydration, diuretics if necessary. |
| **Hypersensitivity reactions** | Rare with parenteral forms; higher risk with intramuscular injections. | Premedication or alternative route may be needed. |
| **Allergic contact dermatitis to topical formulations** | Mild itching/erythema at application site. | Discontinue use and apply mild steroid if severe. |

---

## 5. Contraindications & Precautions

### 5.1 Absolute Contraindications
- Known hypersensitivity or allergy to mefenamic acid, diclofenac, or other NSAIDs.
- Active or recent gastrointestinal bleeding (e.g., peptic ulcer disease).
- Severe renal insufficiency (creatinine clearance  200 ng/mL (or > 300 ng/mL) with no obvious cause, repeat ferritin in 4–6 weeks. If still high, consider iron studies (serum iron, TIBC, transferrin saturation). Evaluate for chronic inflammation or infection. |
| **Anemia** | If hemoglobin

معلومات الشخصي